Please use this identifier to cite or link to this item:
|Title:||Long-term drug treatment of panic disorder.||Austin Authors:||Burrows, Graham D;Judd, F K;Norman, Trevor R||Affiliation:||Department of Psychiatry, University of Melbourne, Austin Hospital, Heidelberg, Victoria, Australia||Issue Date:||16-May-1993||Publication information:||Journal of Psychiatric Research; 27 Suppl 1(): 111-25||Abstract:||Drug treatment of panic disorder with benzodiazepines and antidepressants has been established as efficacious in the short-term (6-8 weeks). The efficacy of medications during long-term (i.e., continuous) treatment has not often been addressed and a review of the evidence is presented. Most data exists for the long-term effectiveness of benzodiazepines. Experience with the triazolobenzodiazepine, alprazolam, is reviewed together with some other high potency drugs, e.g., clonazepam. Tricyclic antidepressants are also effective in the long-term treatment of panic and the relevant studies are presented. Long-term efficacy for monoamine oxidase inhibitors is not as clearly established. The issue of relapse following drug withdrawal is addressed and some strategies for patient management in long-term therapy are discussed.||Gov't Doc #:||7908330||URI:||http://ahro.austin.org.au/austinjspui/handle/1/13164||URL:||https://pubmed.ncbi.nlm.nih.gov/7908330||Type:||Journal Article||Subjects:||Anti-Anxiety Agents.adverse effects.therapeutic use
Antidepressive Agents.adverse effects.therapeutic use
Panic Disorder.drug therapy.psychology
Substance Withdrawal Syndrome.psychology
|Appears in Collections:||Journal articles|
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.